scholarly journals Letter to Editor: Zoonotic Perspective of 2019 Novel Coronavirus Disease (COVID-19)

2021 ◽  
Vol 5 (1) ◽  
pp. 1-3
Author(s):  
Arslan Habib ◽  
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Avian Influenza ◽  
Middle East Respiratory Syndrome ◽  
Current Outbreak ◽  
Novel Coronavirus ◽  
Severe Fever

Recently Biscayart et al. stated that coronaviruses cause deleterious diseases in both humans and animals. In the previous three decades China affected with different kinds of viral outbreaks in which include avian influenza disease in 1997, severe acute respiratory syndrome (SARS) in 2003 and severe fever with thrombocytopenia syndrome (SFTS) in 2010. The current outbreak of novel coronavirus disease (2019-nCoV) is much similar in case of symptoms with SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV).

scholarly journals Does the novel coronavirus 2019 like heart more than the other family members of coronaviruses?

2020 ◽  
Vol 12 (2) ◽  
pp. 156-157
Author(s):  
Mohammad Mostafa Ansari Ramandi ◽  
Mohammadreza Baay ◽  
Nasim Naderi
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Family Members ◽  
Middle East Respiratory Syndrome ◽  
The Other ◽  
The Novel ◽  
The World ◽  
Future Challenges ◽  
Novel Coronavirus ◽  
Coronavirus Infections

The disaster due to the novel coronavirus disease 2019 (COVID-19) around the world has made investigators enthusiastic about working on different aspects of COVID-19. However, although the pandemic of COVID-19 has not yet ended, it seems that COVID-19 compared to the other coronavirus infections (the Middle East Respiratory Syndrome [MERS] and Severe Acute Respiratory Syndrome [SARS]) is more likely to target the heart. Comparing the previous presentations of the coronavirus family and the recent cardiovascular manifestations of COVID-19 can also help in predicting possible future challenges and taking measures to tackle these issues.

scholarly journals Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options

2020 ◽  
Vol 58 (5) ◽  
Author(s):  
Suliman Khan ◽  
Rabeea Siddique ◽  
Muhammad Adnan Shereen ◽  
Ashaq Ali ◽  
Jianbo Liu ◽  
...  
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Clinical Features ◽  
Genome Sequencing ◽  
Therapeutic Strategies ◽  
Therapeutic Options ◽  
Highly Pathogenic ◽  
The Third ◽  
Current Outbreak ◽  
Novel Coronavirus

ABSTRACT The new decade of the 21st century (2020) started with the emergence of a novel coronavirus known as SARS-CoV-2 that caused an epidemic of coronavirus disease (COVID-19) in Wuhan, China. It is the third highly pathogenic and transmissible coronavirus after severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in humans. The source of origin, transmission to humans, and mechanisms associated with the pathogenicity of SARS-CoV-2 are not yet clear, however, its resemblance to SARS-CoV and several other bat coronaviruses was recently confirmed through genome sequencing-related studies. The development of therapeutic strategies is necessary in order to prevent further epidemics and cure infections. In this review, we summarize current information about the emergence, origin, diversity, and epidemiology of three pathogenic coronaviruses with a specific focus on the current outbreak in Wuhan, China. Furthermore, we discuss the clinical features and potential therapeutic options that may be effective against SARS-CoV-2.

scholarly journals A comprehensive review about SARS-CoV-2

2020 ◽  
Vol 15 (9) ◽  
pp. 625-648
Author(s):  
SK Manirul Haque ◽  
Omar Ashwaq ◽  
Abdulla Sarief ◽  
Abdul Kalam Azad John Mohamed
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Respiratory Tract ◽  
Middle East Respiratory Syndrome ◽  
Gastrointestinal Infections ◽  
Comprehensive Review ◽  
Host Interaction ◽  
The World ◽  
Severe Fever

The coronavirus disease (COVID-19) was first identified in China, December 2019. Since then, it has spread the length and breadth of the world at an unprecedented, alarming rate. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2, which causes COVID-19, has much in common with its closest homologs, SARS-CoV and Middle East respiratory syndrome-CoV. The virus–host interaction of SARS-CoV-2 uses the same receptor, ACE2, which is similar to that of SARS-CoV, which spreads through the respiratory tract. Patients with COVID-19 report symptoms including mild-to-severe fever, cough and fatigue; very few patients report gastrointestinal infections. There are no specific antiviral strategies. A few strong medications are under investigation, so we have to focus on proposals which ought to be taken to forestall this infection in a living host.

scholarly journals Extension and Advisory Services during Lockdown due to COVID-19: Efforts by KVK in Barmer District of Rajasthan

2020 ◽  
Vol 35 (1-2) ◽  
Author(s):  
Pradeep Pagaria ◽  
L. R. Choudhary ◽  
Haridayal Choudhary ◽  
Ganga Ram ◽  
Turfan Khan
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Common Cold ◽  
Large Family ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
Advisory Services ◽  
The Common ◽  
Novel Coronavirus

Coronavirus outbreak was first reported in Wuhan, China on 31 December, 2019. Coronavirus (CoV) is a large family of viruses that causes illness. It ranges from the common cold to more severe diseases like Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus is a new strain of virus that has not been identified in human so far.

scholarly journals The necessity for carnivore experimentation in predicting the next zoonotic disease epidemic

2022 ◽  
pp. 1-3
Author(s):  
Freeha Anjum ◽  
Hillary Hale
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Infectious Diseases ◽  
Novel Species ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
The Public ◽  
Bodily Fluids ◽  
Novel Coronavirus ◽  
Human Infections

Zoonoses are human infections or diseases caused by disease spillover from vertebrate animals to people [1]. Spillover is the movement of pathogens from their normal host to a novel species [2]; this can occur through bodily fluids, bites, food, water, or contact with surfaces where infected animals have travelled [3]. Although some zoonoses remain established within populations and primarily affect only one person per spillover (classified as enzootic zoonoses—e.g., rabies), others can be transmitted between people and result in localized, or even global outbreaks [4]. Zoonoses account for over 60% of infectious diseases in humans [4] and can be caused by viruses, parasites, bacteria, or fungi. Of these, viral zoonoses prove to be of greatest detriment to the public on a widespread scale, as they are responsible for numerous epidemics and pandemics, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the novel coronavirus (COVID-19) [5-7]. Research has also been conducted on different taxonomic orders of species, such as Carnivora — placental animals which obtain nutrients from flesh — and their viral spillover risk [11].

scholarly journals Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome Coronavirus

2020 ◽  
Vol 41 (04) ◽  
pp. 568-578 ◽  
Author(s):  
Jaffar A. Al-Tawfiq ◽  
Ziad A. Memish
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Emerging Infectious Diseases ◽  
Case Fatality ◽  
Severe Pneumonia ◽  
Middle East Respiratory Syndrome ◽  
Zoonotic Pathogen ◽  
Clinical Presentations ◽  
The World ◽  
Novel Coronavirus

AbstractEmerging infectious diseases continue to be of a significant importance worldwide with the potential to cause major outbreaks and global pandemics. In 2002, the world had witnessed the appearance of the severe acute respiratory syndrome coronavirus in China which disappeared abruptly within 6 months. About a decade later, a new and emerging novel coronavirus named the Middle East respiratory syndrome coronavirus (MERS-CoV) was described in a patient from Saudi Arabia. These two coronaviruses shared multiple similarities in the epidemiology, clinical presentations, and posed challenges in its prevention and management. Seven years since its discovery, MERS-CoV continues to be a lethal zoonotic pathogen capable of causing severe pneumonia with high case fatality rates and the ability to cause large health care-associated outbreaks.

Recent Patents and Advances on Nanotechnologies against Coronavirus

2020 ◽  
Vol 14 ◽  
Author(s):  
Roozbeh Abedini-Nassab ◽  
Naeemeh Mahdaviyan
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Genome Sequencing ◽  
Middle East Respiratory Syndrome ◽  
Detection Methods ◽  
Prevention Strategies ◽  
Infected People ◽  
The Third ◽  
The World ◽  
Novel Coronavirus

: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the seven known coronaviruses infecting humans; HKU1, 229E, NL63, OC43, acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, the last three of which can cause severe symptoms in patients. COVID-19, previously known as 2019 novel coronavirus, caused by SARS-CoV-2, was first reported in Wuhan, China, in late 2019, and quickly resulted in a major epidemic across the world. Although the origin of SARS-CoV-2 is not clear yet, genome sequencing results suggest that this is the third reported spillover of an animal coronavirus to humans, from 2002. The development of detection, therapeutic, and prevention strategies for COVID-19 is a fundamental task towards curing infected people and competing with the pandemic. Because of their similarities, scientists believe that treatment/detection methods similar to what were used against the illnesses caused by SARS-CoV or MERS-CoV may be effective for curing/detecting COVID-19. Here, we review the recent nanotechnology techniques used for treating and testing SARS-CoV, MERS-CoV, and SARS-CoV-2, and potential therapeutic options for curing COVID-19.

scholarly journals COVID-19 Pandemic Between Severity Facts and Prophylaxis

2021 ◽  
Vol 16 (11) ◽  
pp. 1934578X2110412
Author(s):  
Hui Liu ◽  
Wenxia Zhu ◽  
Yilin Wu ◽  
Caini Jiang ◽  
Lili Huo ◽  
...  
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Infectious Virus ◽  
Middle East Respiratory Syndrome ◽  
The Novel ◽  
Healthy Nutrition ◽  
The World ◽  
Seasonal Flu ◽  
Novel Coronavirus ◽  
Nutrition Habits

Before COVID-19, many viruses have infected humans, so what caused COVID-19 to be considered as a pandemic? COVID-19 belongs to the coronavirus family that includes severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS). This family has caused a large number of deaths all over the world. How risky is the novel coronavirus? People and their careers were disrupted, and many businesses all over the world are now closed. From here, it seems to us that this virus is something that can make people feel afraid. In this article, we will try to understand the severity of this virus, and then disclose the available ways to confront it and ways that might improve the ability to face it, either now or in the future. Upon comparing COVID-19 with seasonal flu, we have found that COVID-19 is about 10 times more deadly, although it is not the most infectious virus. In this review, we will discuss how healthy nutrition and lifestyle may help to prevent and treat diseases, and especially COVID-19. We will focus on how to follow healthy nutrition habits and lifestyles to stop the dangers of COVID-19.

COVID -19 infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment

2021 ◽  
Vol 27 ◽  
Author(s):  
Avneet Kaur ◽  
Vijay Bhalla ◽  
Mohammed Salahuddin ◽  
Syed Obaidur Rahman ◽  
Faheem Hyder Pottoo
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Clinical Features ◽  
Pharmacological Treatment ◽  
Middle East Respiratory Syndrome ◽  
Present Review ◽  
The Novel ◽  
The World ◽  
Novel Coronavirus ◽  
Potential Therapeutics

Abstract:: Coronavirus was first discovered during the year 1930 and since then vrious coronaviruses like HKU1, MERS-CoV , NL63 and SARS-CoV-2 had been found to infect humans. The COVID-19 pandemic caused by SARS-CoV-2 is spreading at an alarming rate thereby created health emergency around the world. SARS-CoV2 is reportedly to be originated from wet animal market of Wuhan, China. Since then the world is searching for effective way to manage and treat the COVID-19 infection. The infections has already multiplied with several folds compared to the number of person infected by Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome. In order to fill the gap of knowledge about this virus, several evidences are required to control it so more lives could be saved. The present review is based on the publicly available literature in order to explore the knowledge regarding epidemiology, virology, diagnosis, clinical features, pharmacological and therapeutic ways to treat the novel coronavirus. This can be helpful in offering novel insights and potential therapeutics in fighting this disease.

Air PDAM Melawan Corona

2020 ◽  
Author(s):  
Gede H Cahyana
Keyword(s):  
Middle East ◽  
Severe Acute Respiratory Syndrome ◽  
Middle East Respiratory Syndrome ◽  
Novel Coronavirus

Organisasi Kesehatan Dunia (WHO) menyatakan bahwa virus Corona baru (novel Coronavirus) berkaitan dengan virus sebelumnya. Virus yang dinamai SARS-CoV-2 ini masih satu keluarga dengan Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV atau SARS) dan Middle East Respiratory Syndrome Coronavirus (MERS-CoV atau MERS). Artinya, virus-virus tersebut memiliki kesamaan sifat fisika dan biokimia. Tetapi yang paling bahaya adalah virus hasil mutasi terakhir seperti Corona ini. Penyakit akibat virus baru ini dinamai CoViD-19, Coronavirus Disease-19, penyakit karena Corona yang muncul tahun 2019.

Sign in / Sign up

Export Citation Format

Share Document